Transdermal Or Percutaneous Patents (Class 424/449)
-
Patent number: 11058651Abstract: A topical composition for nociceptive and neuropathic pain relief comprising one or more of menthol, camphor, methyl sulfonyl methane, lidocaine, Arinica montana, harpagophytum tincture, Emu oil, maqui powder, turmeric oil and in some embodiments methyl salicylate or capsaicin with Cannabis sativa.Type: GrantFiled: December 10, 2019Date of Patent: July 13, 2021Inventor: Bob Fuladi
-
Patent number: 11045483Abstract: The subject-matter of the present invention is the use of a therapeutic composition comprising, in an applying carrier, at least one essential oil for relieving muscle and/or joint pain in an animal subject, wherein said composition topically treats an area of the skin of said subject, characterized in that said composition comprises methyl salicylate, which constitutes, with at least one essential oil of the composition containing same in only a small amount or not at all, an active agent within which the rate of transport of the methyl salicylate through the skin is increased by virtue of the oil, which is an essential oil.Type: GrantFiled: August 9, 2016Date of Patent: June 29, 2021Assignee: AB7 INNOVATION S.A.S.U.Inventor: Rene Chelle
-
Patent number: 11007385Abstract: The invention describes methods and agents for inducing in the skin one or more effects selected from stimulating fibroblast migration, stimulating elastin production, reducing expression of inflammatory factors and upregulating specific genes, thereby preventing skin cell aging processes and repairing skin damage. In preferred embodiments, the methods and agents comprise active extracts produced from fish eggs.Type: GrantFiled: December 6, 2013Date of Patent: May 18, 2021Assignee: REGENICS ASInventors: Runhild Gammelsaeter, Jan Remmereit, Gry Kalstad Lonne, Camilla Margrethe Haglerod
-
Patent number: 10998091Abstract: Aspects of the invention include systems for monitoring compliance of a patient with a patch dosage regimen and, where necessary, providing rapid, economical intervention when non-compliance is detected. In some instances, the systems include: a patch comprising an active agent and a patch tag; a reader configured to detect the patch tag; one or more processing devices; and a compliance determination module comprising a computer-readable storage medium comprising instructions that, when executed by the one or more processing devices, determine compliance information from data received from the reader. The compliance information includes data that may be employed to determine whether the patient is complying with the patch dosage regimen. Also provided methods of using the systems, e.g., to monitor patient compliance, as well as components of the systems, e.g., patches, readers, etc.Type: GrantFiled: February 3, 2020Date of Patent: May 4, 2021Inventor: Sandeep Patil
-
Patent number: 10993910Abstract: A biopatch, a bioheater, a biosensor and a bioelectronic patch device are provided. The biopatch comprises a polymer film comprising a biopolymer and a drug loaded in the polymer film. The biopolymer may comprise one or more than one of a bioabsorbable polymer, a biodegradable polymer and a biocompatible polymer. The biopolymer may comprise oxidized starch. The drug may comprise a first drug chemically combined with the oxidized starch and a second drug physically combined with the oxidized starch. The bioheater comprises a heater comprising biometal. The biometal may comprise Mg or Fe. The heater can be controlled wirelessly by an alternating magnetic field.Type: GrantFiled: December 7, 2016Date of Patent: May 4, 2021Inventors: Daehyeong Kim, Seunghong Choi, Taeghwan Hyeon, Jongha Lee, Hyerim Cho, Hyunseon Seo
-
Patent number: 10987316Abstract: Described are transdermal drug delivery systems for the transdermal administration of tertiary amine drugs, such as rivastigmine, fentanyl or rotigotine, comprising a polymer matrix comprising a free base form of the drug and at least one carboxyl group-containing compound. In some embodiments, the systems include a rate-controlling membrane and a skin-contacting face adhesive apart from the polymer matrix.Type: GrantFiled: March 13, 2014Date of Patent: April 27, 2021Assignee: NOVEN PHARMACEUTICALS, INC.Inventors: Jun Liao, Takito Shima, Puchun Liu, Steven Dinh
-
Patent number: 10980753Abstract: The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of asenapine comprising a self-adhesive layer structure containing a therapeutically effective amount of asenapine, such asenapine TTS for use in a method of treatment, processes of manufacture of such TTS as well as asenapine and transdermal therapeutic systems containing asenapine for use in a method of treatment and to a method of treating a human patient by transdermal administration of asenapine.Type: GrantFiled: June 19, 2019Date of Patent: April 20, 2021Assignee: LTS LOHMANN THERAPIE-SYSTEME AGInventors: Patrick Mohr, René Rietscher, René Eifler, Olga Bourquain
-
Patent number: 10963118Abstract: An electrode structure and a touch panel including the electrode structure are provided. The electrode structure includes a membrane layer and a metallic nanowires layer having metallic nanowires. A first portion of the metallic nanowires layer is covered by the membrane layer, and a second portion of the metallic nanowires layer is exposed out of the membrane layer. The membrane layer is made of a copolymer formed by mixing two or more materials having different functional groups.Type: GrantFiled: February 11, 2020Date of Patent: March 30, 2021Assignee: Cambrios Film Solutions CorporationInventors: Chung-Chin Hsiao, Siou-Cheng Lien, Chia-Yang Tsai, Yi-Wen Chiu, Shu-Ping Hsu
-
Patent number: 10945945Abstract: Stabilized skin care compositions are described. The compositions comprise a fish oil component that yields a product of oxidation and the component is stabilized with a radical scavenger, a peroxide decomposer and hydroxylated fatty acid and/or a derivative thereof.Type: GrantFiled: December 12, 2017Date of Patent: March 16, 2021Assignee: CONOPCO, INC.Inventors: Marina Tomashevskaia, Hasiba Bekto
-
Patent number: 10918607Abstract: Propynylaminoindan (e.g., Rasagiline) transdermal compositions are provided. Aspects of the transdermal compositions include a matrix which includes the propynylaminoindan, a pressure sensitive adhesive that includes an acrylate copolymer and a cationic acrylic copolymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.Type: GrantFiled: October 25, 2013Date of Patent: February 16, 2021Assignee: Teikoku Pharma USA, Inc.Inventors: Richard D. Hamlin, Amit Jain, Jianye Wen
-
Patent number: 10918686Abstract: Disclosed is an oleo gel composition including essential combination of synergistically acting phyto-active materials, non-psychotropic phytocannabinoids from the plant of Cannabis sativa: Cannabidiol, Cannabidiolic acid, Cannabivarin and Cannabigerol in combination with extract of Olive europaea Fruit Oil, Mentha arvensis leaf oil, and Silica colloidal anhydrous ensuring the delivery of cannabinoids to the deep tissues in order to reduce pain and inflammation of skeletal muscles and joints caused by trauma or/and induced by arthritis/osteoarthritis.Type: GrantFiled: April 7, 2017Date of Patent: February 16, 2021Assignee: UAB SatimedInventor: Juozas Siurkus
-
Patent number: 10912734Abstract: A pharmaceutical long acting depot composition is provided as an aid to smoking cessation treatment. The formulation comprises a therapeutically effective amount of varenicline or its pharmaceutically acceptable derivative and pharmaceutically acceptable excipients. The process of preparation of the formulation is also provided.Type: GrantFiled: May 15, 2019Date of Patent: February 9, 2021Assignee: Cipla LimitedInventors: Geena Malhotra, Sarabjit Singh
-
Patent number: 10898503Abstract: Base-labile crosslinkers, base-labile conjugates comprising such crosslinkers, methods of their synthesis and use are disclosed.Type: GrantFiled: January 1, 2016Date of Patent: January 26, 2021Inventor: Mark Quang Nguyen
-
Patent number: 10898489Abstract: The present invention generally relates to the transdermal delivery of various compounds. In some aspects, transdermal delivery may be facilitated by the use of a hostile biophysical environment. One set of embodiments provides a composition for topical delivery comprising a phosphodiesterase type 5 inhibitor and/or a salt thereof, and optionally, a hostile biophysical environment and/or a nitric oxide donor. In some cases, the composition may be stabilized using a combination of a stabilization polymer (such as xanthan gum, KELTROL® BT and/or KELTROL® RD), propylene glycol, and a polysorbate surfactant such as Polysorbate 20, which combination unexpectedly provides temperature stability to the composition, e.g., at elevated temperatures such as at least 40° C. (at least about 104° F.), as compared to compositions lacking one or more of these.Type: GrantFiled: April 13, 2020Date of Patent: January 26, 2021Assignee: Strategic Science & Technologies, LLCInventor: Eric T. Fossel
-
Patent number: 10888532Abstract: A patch comprising: a backing layer; and an adhesive layer, wherein the adhesive layer contains at least one drug selected from the group consisting of butorphanol and pharmaceutically acceptable salts thereof and a silicone-based adhesive base, and a mass per unit area of the adhesive layer is 30 to 90 g/m2.Type: GrantFiled: December 21, 2017Date of Patent: January 12, 2021Assignee: HISAMITSU PHARMACEUTICAL CO., INC.Inventors: Naoko Fujita, Takito Shima, Kazuya Kominami, Naoyuki Uchida
-
Patent number: 10874338Abstract: Devices, systems, methods and kits for releasably mounting a medical device on the body or skin of a user are provided. Embodiments include a holder or mounting unit or structure that retains a medical device in a fixed position on a body part of a user or host, such as on the surface of the skin, and/or provides physical and/or electrical coupling to one or more additional components which may be operatively positioned above and/or below the surface of the skin.Type: GrantFiled: June 19, 2020Date of Patent: December 29, 2020Assignee: ABBOTT DIABETES CARE INC.Inventor: Gary Ashley Stafford
-
Patent number: 10864172Abstract: A transdermal patch is provided for use during oil delivery to a user's skin. The patch has a first foam member and a second foam member positioned adjacent the first foam member. An adhesive member is attached to the second foam member for securing the patch to a user's skin. A release liner covers and extends across the adhesive member. A gap can be formed between the first foam member and the second foam member and surrounds the first foam member. The first foam member has a thickness which is greater than a thickness of the second foam member.Type: GrantFiled: March 21, 2019Date of Patent: December 15, 2020Assignee: CHEMSULTANTS INTERNATIONAL INC.Inventors: Berryinne Decker, Keith Muny, Gary Avalon, Brian Buehner
-
Patent number: 10806914Abstract: Disclosed are composite microneedles arrays including microneedles and a film overlaying the microneedles. The film includes a plurality of nano-sized structures fabricated thereon. Devices may be utilized for interacting with a component of the dermal connective tissue. A random or non-random pattern of structures may be fabricated such as a complex pattern including structures of differing sizes and/or shapes. Devices may be beneficially utilized for delivery of an agent to a cell or tissue. Devices may be utilized to directly or indirectly alter cell behavior through the interaction of a fabricated nanotopography with the plasma membrane of a cell and/or with an extracellular matrix component.Type: GrantFiled: July 20, 2018Date of Patent: October 20, 2020Assignee: SORRENTO THERAPEUTICS, INC.Inventor: Russell Frederick Ross
-
Patent number: 10799691Abstract: A needle assembly for transdermal administration including a substrate having a first surface and a second surface opposite to the first surface, and fine needles projecting perpendicularly from the first surface. The substrate has grooves on at least one of the first surface and the second surface, and the grooves are formed such that the substrate is deformable following a surface shape of a skin to allow axes of the fine needles to extend in a direction normal to the surface of the skin.Type: GrantFiled: May 4, 2017Date of Patent: October 13, 2020Assignee: TOPPAN PRINTING CO., LTD.Inventors: Daizo Uemura, Kazuhiko Shiomitsu
-
Patent number: 10786574Abstract: The present disclosure is directed to transdermal and moisturizing compositions.Type: GrantFiled: March 5, 2019Date of Patent: September 29, 2020Inventor: Steven Hoffman
-
Patent number: 10786487Abstract: This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.Type: GrantFiled: January 14, 2019Date of Patent: September 29, 2020Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.Inventors: Mark D. Soll, Joseph K. Rosentel, Jr., James Pate, Natalya Shub, Monica Tejwani-Motwani, Carol Belansky
-
Patent number: 10772871Abstract: Aspects of the invention include transdermal delivery devices for delivering dexmedetomine to a subject, where the transdermal delivery devices include a single layer matrix dexmedetomine composition. Transdermal delivery devices according to certain embodiments include dexmedetomidine and a pressure sensitive adhesive provided as a single layer formulation. Also provide are methods of using the subject transdermal delivery devices to deliver dexmedetomidine to a subject, as well as kits containing the transdermal delivery devices.Type: GrantFiled: October 3, 2014Date of Patent: September 15, 2020Assignee: Teikoku Pharma USA, Inc.Inventors: Adchara Pongpeerapat, Amit Jain, Bret Berner, Jianye Wen, Jutaro Shudo
-
Patent number: 10765749Abstract: Non-aqueous patches comprising lidocaine, which is not dissolved and is present in a crystalline state, have poor permeability to the skin. Therefore, non-aqueous patches have a high concentration of lidocaine. It is pointed out that lidocaine has an adverse effect on the heart. Prolonged use of a high concentration of lidocaine causes side effects, such as shock, rubor, and irritating sensation. External preparations comprising more than 5 mass % of lidocaine are designated as powerful drugs, and cannot be used as household (nonprescription) medicine. Provided is a non-aqueous patch that is effective to relieve muscle pain, the non-aqueous patch comprising lidocaine and/or its reactant, and a dissolving agent composed of an organic acid and a polyalcohol, which are contained in a base.Type: GrantFiled: February 8, 2018Date of Patent: September 8, 2020Assignees: ITOCHU CHEMICAL FRONTIER Corporation, OISHI KOSEIDO CO., LTD.Inventors: Tatsuya Mori, Naoyuki Saida
-
Patent number: 10758528Abstract: The presently described technology provides compositions comprising aryl carboxylic acids and, for example NSAIDs, chemically conjugated to oxymorphone (4,5-?-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one) to form novel prodrugs/compositions of oxymorphone, including benzoates, salicylates, propionates, fenamates, and acetates, which have a decreased potential for abuse of oxymorphone. The present technology also provides methods of treating patients, pharmaceutical kits and methods of synthesizing conjugates of the present technology.Type: GrantFiled: September 17, 2019Date of Patent: September 1, 2020Assignee: KemPharm, Inc.Inventors: Travis Mickle, Sven Guenther, Sanjib Bera, Jaroslaw Kanski, Andrea Martin
-
Patent number: 10758619Abstract: Formulations for chemoprevention of oral cancer and precancerous lesions, and for methods for preparing the formulations are described.Type: GrantFiled: November 15, 2011Date of Patent: September 1, 2020Assignees: THE OHIO STATE UNIVERSITY, THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Susan R. Mallery, Peter E. Larsen, Gary D. Stoner, Steven P. Schwendeman, Kashappa-Goud Desai
-
Patent number: 10751265Abstract: A multilayer beauty care product or method is provided. The beauty care product has a water soluble film zone that includes a water soluble film forming polymer and a cosmetic composition with an effective amount of a skin active agent. The product also has a barrier patch having a backing layer and a pressure sensitive adhesive zone. The adhesive zone and the water soluble film zone are continuous, discontinuous, or a combination thereof. The product exhibits a dynamic modulus.Type: GrantFiled: December 15, 2017Date of Patent: August 25, 2020Assignee: The Procter & GambleInventors: Emily Charlotte Boswell, Jack Alan Hunter, Michael Joseph Roddy, Elizabeth Anne Wilder
-
Patent number: 10716925Abstract: Disclosed is a micro-needle including a tip formed using medicine that penetrates into the skin and melts therein; and at least one guide groove each in a stepped shape inward from the outer surface of the tip, and provided to the tip. The micro-needle configured as above may be used to administer a fixed quantity of medicine within a relatively short period of time. Also, since a guide space stepped based on the tip is provided to a base that supports the tip, a large amount of medicine may easily penetrate into the skin.Type: GrantFiled: November 17, 2016Date of Patent: July 21, 2020Assignee: QuadMedicineInventor: Sun Young Baek
-
Patent number: 10717904Abstract: An adhesive preparation containing bisoprolol includes a backing and a pressure-sensitive adhesive layer formed on one side of the backing. The pressure-sensitive adhesive layer contains a polymer prepared through copolymerization of monomer components including a hydroxyl group-containing monomer and an alkyl (meth)acrylate monomer (component (A)), a polymer prepared through copolymerization of monomer components including a methyl methacrylate monomer and a butyl methacrylate monomer (component (B)), and bisoprolol (component (C)).Type: GrantFiled: June 17, 2016Date of Patent: July 21, 2020Assignee: TOA EIYO LTD.Inventors: Eriko Abe, Yu Tachikawa, Satoshi Ameyama, Naoko Urushihara, Jun Ishikura, Tetsuya Nakamura, Akira Yokouchi, Yoshitaka Inoue, Kazuhiro Aoyagi, Tomoya Tanaka, Naohiro Nishida, Kunihiro Minami
-
Patent number: 10702469Abstract: A non-aqueous topical solution composition of pharmaceutically acceptable salt of diclofenac is disclosed. The non-aqueous topical solution composition comprises therapeutically effective amount of pharmaceutically acceptable salt of diclofenac, solublizer, penetration enhancer and solvent, and optionally a humectant, counter irritant, additional penetration enhancer and anti-oxidants and a process for preparing the same.Type: GrantFiled: June 9, 2008Date of Patent: July 7, 2020Assignee: TROIKAA PHARMACEUTICALS LTD.Inventor: Ketan R. Patel
-
Patent number: 10688159Abstract: A treatment for pruritus is described that is based upon amylase. The amylases (?-, ?-, ?-amylase) are noted for the cleavage of the ?-glycosidic bonds of polysaccharides, yielding lower molecular weight carbohydrate/sugar fragments. It has now been found that ?-amylase is effective in the reduction of pruritus (itching) of affected tissue.Type: GrantFiled: March 23, 2016Date of Patent: June 23, 2020Assignee: ROCHAL INDUSTRIES, LLCInventors: Joseph Charles Salamone, Ann Beal Salamone, Kelly Xiaoyu Chen Leung, Katelyn Elizabeth Reilly
-
Patent number: 10675254Abstract: Iontophoretic devices for transdermal delivery of a sphingosine-1-phosphate receptor agonist active agent are provided. Also provided are methods of transdermally delivering a therapeutically effective amount of a sphingosine-1-phosphate receptor agonist active agent to a subject, e.g., to treat immune system disorders such as multiple sclerosis. Packaged iontophoretic systems, kits including iontophoretic devices, and methods of making iontophoretic devices are also provided.Type: GrantFiled: August 29, 2014Date of Patent: June 9, 2020Assignee: Teikoku Seiyaku Co., Ltd.Inventor: Adchara Pongpeerapat
-
Patent number: 10660863Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, said system being suitable for an application period of at least three days, comprising the layers arranged in the following order with respect to each other: a) a cover layer, b) an active substance layer comprising a polymer matrix containing the active substance, c) an adhesive layer comprising a contact adhesive, which consists of a mixture of one or more polyisobutylenes and one or more polybutenes, and d) a pull-off layer.Type: GrantFiled: December 14, 2011Date of Patent: May 26, 2020Assignee: Luye Pharma AGInventors: Britta Langer, Björn Schurad, Heike Prinz
-
Patent number: 10660962Abstract: The present embodiments may relate to topically delivered compounded medications for the treatment of scar tissue, skin disorders, and/or other ailments. In one aspect, a transdermal cream or gel may provide for the effective administration of multiple medications simultaneously. Preferably, a silicone-based gel may be provided as a base composition and may have a non-zero percentage of silicone or silicone variant. The silicone-based gel may comprise cyclopentasiloxane, polysilicone-11, dimethicone, and C30-45 alkyl cetearyl dimethicone crosspolymer, and include several active ingredients, such as glucocorticoids, antihistamines, and nerve depressants. The silicone-based gel may include a combination of fluticasone, loratadine, and gabapentin. The concentrations of fluticasone and loratadine may be relatively low, while that of gabapentin moderately high. The silicone-based gel may also have one or more local anesthetics, such as prilocaine and/or lidocaine.Type: GrantFiled: September 4, 2018Date of Patent: May 26, 2020Assignee: CMPD Licensing, LLCInventors: Jay Richard Ray, II, Charles D. Hodge
-
Patent number: 10653700Abstract: The present disclosure provides a safe method for anesthesia or the treatment of pain by safely administering an amount of active agent to a patient while reducing the incidence or severity of suppressed respiration. The present disclosure provides a pharmaceutical composition comprising a therapeutic agent and a chemoreceptor respiratory stimulant. In one aspect, the compositions oppose effects of respiratory suppressants by combining a chemoreceptor respiratory stimulant with an opioid receptor agonist or other respiratory-depressing drug. The combination of the two chemical agents, that is, the therapeutic agent and the respiratory stimulant, may be herein described as the “drugs.” The present compositions may be used to treat acute and chronic pain, sleep apnea, and other conditions, leaving only non-lethal side effects.Type: GrantFiled: June 6, 2018Date of Patent: May 19, 2020Inventor: John Hsu
-
Patent number: 10632105Abstract: The invention relates to the selective targeting of specific ?2 adrenergic receptor subtypes for facilitating and also restoring standing and walking in a subject affected by spinal cord disorders, in particular spinal cord injury. In particular, the improvement of locomotion by targeting specific receptor subtypes can be achieved by stimulation of the ?2c receptor subtype using an ?2c specific agonist or by blocking the ?2a receptor subtype using ?2a antagonists. A combination of an ?2c agonist and an ?2a antagonist is also provided for a synergistic effect. Alternatively, a large ?2 agonist can be used in combination with an ?2a antagonist to achieve specific stimulation of the ?2c receptor. Pharmaceutical compositions, kit-of-parts and therapeutic systems comprising said agonists/antagonists as active agents are objects of the present invention.Type: GrantFiled: June 27, 2014Date of Patent: April 28, 2020Assignee: ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL)Inventors: Grégoire Courtine, Quentin Barraud, Pavel Musienko
-
Patent number: 10624834Abstract: Disclosed is a composition that begins as a multi-phase structure including a plurality of immiscible liquids that, upon agitation, encapsulates and suspends one of the plurality of liquids (e.g., in spheres). In some embodiments, the composition includes a water phase and an anhydrous phase. The composition can include a thickener added to the water phase to allow the water molecules to encapsulate the anhydrous phase into spheres. The formed spheres are stable and can be configured to last for specific durations depending on modifications to the formula. In some embodiments, the spheres can release back into the multi-phase structure after a specific period of time. The formulations disclosed herein can act as a vehicle or a base formulation to which additional ingredients can be added. The disclosed formulation, in addition to enabling the intermixing of two immiscible liquids, can provide a number of additional benefits.Type: GrantFiled: December 14, 2018Date of Patent: April 21, 2020Assignee: Benchmark Cosmetic Laboratories, Inc.Inventors: Susan Goldsberry, Lyndon S. Garcines, Yen H. Ly
-
Patent number: 10624862Abstract: The invention relates to a tamper-resistant, oral pharmaceutical dosage form comprising a pharmacologically active ingredient having psychotropic action and an ethylene-vinyl acetate (EVA) polymer which provides resistance against solvent extraction, resistance against grinding, and resistance against dose-dumping in aqueous ethanol.Type: GrantFiled: July 10, 2014Date of Patent: April 21, 2020Assignee: GRÜNENTHAL GMBHInventors: Klaus Wening, Lutz Barnscheid, Sebastian Schwier, Anja Geißler
-
Patent number: 10603066Abstract: A minimally invasive skin treatment system includes a platform having a recessed area on its bottom and one or more injection ports orthogonal to its top, each injection port including a through-hole to the recessed area. The system includes an injection device including a needle slidably disposed in a selective port such that the needle passes into the recessed area and percutaneously through a dermis disposed within the recessed area. A nozzle is configured to discharge a fluid at a high pressure in a direction orthogonal to an axis of the needle and parallel to the top of the platform to cut create a plane of dissection within the subcutaneous tissue.Type: GrantFiled: May 10, 2016Date of Patent: March 31, 2020Assignee: ULTHERA, INC.Inventors: Sowmya Ballakur, Robert L. Clark, III, James E. Chomas, Ben F. Brian, III, David M. Clapper
-
Patent number: 10568905Abstract: A pharmaceutical composition useful for preventing and treating retinal neurodegeneration related diseases comprising chromium chloride and magnesium sulfate, thickening agent, penetration enhancer, and pharmaceutical acceptable carrier, diluent or excipient. Further disclosed is a method for treating and preventing retinal neurodegeneration related diseases utilizing the composition.Type: GrantFiled: July 15, 2019Date of Patent: February 25, 2020Assignee: Metabolic Therapy Inc.Inventor: Kenneth O. Russell
-
Patent number: 10568961Abstract: The present invention provides a photosensitising composition comprising a mixture of at least one oxygen carrier, at least one oxidising agent and at least one surfactant, and its uses. The ratio of the at least one oxygen carrier to the at least one oxidising agent to the at least one surfactant may be in the range of 50:40:10 to 80:19.8:0.2. The photosensitising composition may be used for treating and/or preventing conditions caused by microorganisms.Type: GrantFiled: April 6, 2009Date of Patent: February 25, 2020Assignee: DENTSPLY SIRONA Inc.Inventors: Anil Kishen, Saji George
-
Patent number: 10557041Abstract: Anti-corrosion composition comprising at least a first polyisobutylene with a Staudinger index J0 ranging from about 15 cm3/g to about 98 cm3/g and an average relative molar mass MV ranging from about 32,000 g/mol to about 280,000 g/mol and at least a second polyisobutylene with a Staudinger index J0 ranging from about 105 cm3/g to about 238 cm3/g and an average relative molar mass MV ranging from about 350,000 g/mol to about 900,000 g/mol.Type: GrantFiled: November 15, 2016Date of Patent: February 11, 2020Assignee: DENSO-HOLDING GMBH & COInventors: Thomas Markus Kaiser, Oleg Gryshchuk
-
Patent number: 10548854Abstract: Transdermal patches and devices for delivery of therapeutic drug and/or cosmetic formulations through an intact or porated skin barrier are described. Active-infusion delivers controlled dosing over a period of time to provide long-term efficacy. Methods and devices for preparing active-infusion patches for controlled dose delivery by nonelectronic devices and methods of skin poration that is safe and painless are described.Type: GrantFiled: September 23, 2013Date of Patent: February 4, 2020Assignee: The Hong Kong University of Science and TechnologyInventors: King Lun Yeung, Wai Kit Wong, Siu Ming Kwan, Li Yin Chau, Ho Yee Timothy Poon, Ming Hung Thomas Lee, Albert Hee Lum Chow
-
Patent number: 10553132Abstract: Provided are methods for creating a pressurized cadaver model used for surgical procedure training. In the method the internal jugular veins, common carotid arteries, brachial arteries, superficial femoral arteries and femoral veins thereof of a cadaver are exposed. One internal jugular vein is ligated and a drainage tube is disposed in the other internal jugular vein. An arterial catheter is inserted into one brachial artery and connected to a pressure transducer and an arterial cannula is placed in a carotid artery and connected to a fusion pump. Fluid is injected into the artery through the cannulated carotid artery. A representative example of the surgical procedure includes resuscitative endovascular balloon occlusion of the aorta.Type: GrantFiled: September 17, 2015Date of Patent: February 4, 2020Assignee: University of Maryland, BaltimoreInventors: Megan Brenner, Thomas Scalea
-
Composition for patch preparation comprising drug, organic solvent, lipophilic mass base, and powder
Patent number: 10543275Abstract: The present disclosure provides a composition for a non-aqueous patch preparation with excellent adhesibility which can sustainedly release a drug. The patch preparation can improve the adhesibility of the patch preparation and the release property of a drug by the addition of a powder ingredient the long-time sustention of the adhesibility of tape preparations enables an improvement of the transdermal absorbability and the sustained release of a drug.Type: GrantFiled: June 18, 2013Date of Patent: January 28, 2020Assignee: MEDRX CO., LTD.Inventors: Hidetoshi Hamamoto, Katsuhiro Yamanaka, Takahiro Tanimoto -
Patent number: 10525020Abstract: Disclosed herein are methods for treating subjects having ADHD identifiable by levels of 3-IS in blood.Type: GrantFiled: February 9, 2016Date of Patent: January 7, 2020Assignee: Laboratory Corporation of America HoldingsInventors: Ute Geigenmuller, Doris Damian, Maciej Pacula, Mark A. DePristo
-
Patent number: 10508789Abstract: A hollow light guide luminaire where a light source conveys light through a light ingress surface of a nominally hollow light guide with a narrow portion and a wide portion. The light guide provides means of transporting light via total internal reflection within the light guide from the light source positioned at one of the narrow portion or the wide portion to the other of the wide portion or the narrow portion wherefrom light is emitted from the light guide into the environment surrounding the luminaire.Type: GrantFiled: October 6, 2016Date of Patent: December 17, 2019Assignee: LOOM INC.Inventor: Matthew Kennedy
-
Patent number: 10493254Abstract: Disclosed are a patch, system, and method for delivery of a permeant composition into a subject via at least one formed pathway through a biological membrane of the subject. The patch comprises a matrix, at least one hydrophilic permeant disposed within the matrix, wherein at least a portion of the permeant can dissolve in biological moisture received from the subject, and at least one permeability enhancer disposed within the matrix. Also disclosed are systems and methods for delivery of a permeant composition into a subject via at least one formed pathway through a skin layer of the subject.Type: GrantFiled: June 24, 2017Date of Patent: December 3, 2019Assignee: Nitto Denko CorporationInventors: Frank Tagliaferri, Alan Smith, David Enscore, Gaurav Tolia, Mirek Baudys
-
Patent number: 10478455Abstract: Tetrathiomolybdate is for use in therapy of a condition requiring reduced metabolism of an organ or whole body, e.g. myocardial infection, stroke or ischaemia-reperfusion injury.Type: GrantFiled: September 28, 2012Date of Patent: November 19, 2019Assignee: UCL BUSINESS LTDInventors: Mervyn Singer, John Francis Martin, Alex Peter Dyson
-
Patent number: 10471131Abstract: The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.Type: GrantFiled: December 28, 2015Date of Patent: November 12, 2019Assignee: Hybrid Medical, LLCInventors: Jeff Twidwell, Joel Buckley, Harold Hoium
-
Patent number: 10463629Abstract: Embodiments of the invention provide patches for the transdermal delivery of iron-containing compositions to an individual suffering from an iron deficiency. Many embodiments provide an iontophoretic patch for the transdermal delivery of a therapeutically effective amount of iron. The patch comprises an electrode and a reservoir containing a composition comprising ionic iron for the delivery of the therapeutically effective amount of iron. Various embodiments provide methods of using embodiments of the iontophoretic patch for delivering a therapeutically effective amount of iron to an individual suffering from one more forms of iron deficiency including iron deficiency anemia. Such methods can be used for treating and/or preventing the iron deficiency. The amount of delivered iron can be adjusted depending upon various treatment parameters such as patient weight and type and amount of iron deficiency.Type: GrantFiled: February 17, 2015Date of Patent: November 5, 2019Assignee: FE3 MEDICAL, INC.Inventor: Ronald J. Berenson